← SynDRA
BEPOTASTINE
SynDRA canonical compound SYN0023606 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Histamine-1 Receptor Antagonist
- Anti-Allergic Agents
Cross-references
Synonyms
- bepotastine besilate
- bepreve
- bepotastine besylate
- Bepotastina
- Betotastine
- Tau 284
- TAU-284DS
- Talion (TN)
- (S)-4-(4-((4-Chlorophenyl)(2-pyridil)methoxy)piperidino)butylic acid
- 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid
- 4-[4-[(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
- HYD2U48IAS
- bepotastina
- tau-284
- bepotastinum
- CHEBI:71204
- RefChem:56382
- DTXCID201334062
- Bepotastine >90%
- MFCD06798155
- Bepotastine [INN]
- UNII-HYD2U48IAS
- Bepotastine [USAN:INN]
- BEPOTASTINE [MI]
- Bepotastine (USAN/INN)
- BEPOTASTINE [USAN]
- BEPOTASTINE [VANDF]
- BEPOTASTINE [MART.]
- SCHEMBL29459
- BEPOTASTINE [WHO-DD]
- GTPL7466
- orb1299407
- orb3025862
- SCHEMBL29440897
- TQP0323
- GLXC-07023
- CS-M1828
- CS-M1895
Reported adverse events
Look up BEPOTASTINE in the interactive SynDRA portal →